InsidersTradesSigma
Total declarations
Company
▲ Purchases (17 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
17
Disclosed sells
0
T+90 hit rate
17%
T+90 mean return
-21.1%
Across 6 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the complete record of transactions filed by Depasquale Michael W, Chief Executive Officer. Insider active across 1 company, notably BIO KEY International INC. Aggregated, 32 filings have been recorded. Breakdown: 17 buys · 0 sell. Total volume traded: €86k. History available since 20 May 2021. The latest transaction was filed on 31 December 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Depasquale Michael W
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations32 total
250 sharesCommon StockSEC:0001437749-26-022517:0
2,500 shares@ US$0.461.0% of flowCommon StockSEC:0001437749-26-000373:0
2,500 shares@ US$0.751.6% of flowCommon StockSEC:0001437749-25-029226:0
Canonical exit: 14 Dec 2025 (T+90)
2,500 shares@ US$0.750.035% mcap2.1% of flowCommon StockSEC:0001437749-25-029320:0
Canonical exit: 14 Dec 2025 (T+90)
45,000 shares0Common StockSEC:0001437749-25-028288:0
139 shares@ US$0.700.1% of flowCommon StockSEC:0001437749-25-022023:0
5,000 shares@ US$0.783.5% of flowCommon StockSEC:0001437749-25-020375:0
Canonical exit: 11 Sept 2025 (T+90)
4,000 shares@ US$0.833.2% of flowCommon StockSEC:0001437749-25-019370:0
Canonical exit: 1 Sept 2025 (T+90)
5,000 shares@ US$0.814.0% of flowCommon StockSEC:0001437749-25-019230:0
Canonical exit: 1 Sept 2025 (T+90)
139 shares@ US$1.400.2% of flowCommon StockSEC:0001437749-25-000213:0
24,000 shares0Common StockSEC:0001437749-24-024503:0
24,000 shares0Common StockSEC:0001437749-24-024515:0
139 shares@ US$1.3940.2% of flowCommon StockSEC:0001437749-24-022004:0
139 shares@ US$2.550.3% of flowCommon StockSEC:0001437749-24-000439:0
20,000 shares@ US$0.182.8% of flowCommon StockSEC:0001437749-23-033457:0
Canonical exit: 29 Feb 2024 (T+90)
165,000 shares@ US$0.17522.9% of flowCommon StockSEC:0001437749-23-029784:0
Canonical exit: 28 Jan 2024 (T+90)
100 shares@ US$0.510.0% of flowCommon StockSEC:0001437749-23-025845:0
Canonical exit: 11 Dec 2023 (T+90)
35,000 shares0Common StockSEC:0001437749-23-024950:0
2,500 shares@ US$0.49731.0% of flowCommon StockSEC:0001437749-23-019324:0
5,000 shares@ US$0.7152.7% of flowCommon StockSEC:0001437749-23-017774:0
Canonical exit: 14 Sept 2023 (T+90)
2,500 shares@ US$0.49731.0% of flowCommon StockSEC:0001437749-23-000716:0
1,000 shares@ US$1.68761.4% of flowCommon StockSEC:0001437749-22-022571:0
Canonical exit: 14 Dec 2022 (T+90)
1,265 shares@ US$1.601.7% of flowCommon StockSEC:0001437749-22-022488:0
Canonical exit: 13 Dec 2022 (T+90)
2,500 shares@ US$1.50453.0% of flowCommon StockSEC:0001437749-22-016562:0
2,000 shares@ US$1.660.071% mcap4.2% of flowCommon StockSEC:0001437749-22-015017:0
Canonical exit: 12 Sept 2022 (T+90)
25 of 32 declarations
About Depasquale Michael W
DEPASQUALE MICHAEL W is Directeur Général and Chief Executive Officer at BIO KEY International INC (XNAS). He has filed 32 forms in total, and across the recent sample of 32 filings the transactions are acquisitions, with EUR 86298 of buys and EUR 0 of sells between 2021-05-21 and 2026-07-02.
